Zoom Logo

COVID-19 Monoclonal Antibody Therapy - Shared screen with speaker view
Becky Snead ~ NASPA
10:09
I can drop off and listen to recording
John Clay Kirtley
18:53
https://www.pharmacyboard.arkansas.gov/home/covid-19/
Elizabeth W. Borella
21:57
Bam Extension:https://www.phe.gov/emergency/events/COVID19/investigation-MCM/Bamlanivimab/Pages/20Aug21-announcement.aspx
atul kothari
22:11
https://www.healthy.arkansas.gov/images/uploads/pdf/EMS_Template_Protocol_for_COVID-19_Monoclonal_Antibody_Administration_August_2021.pdf
Elizabeth W. Borella
22:54
REGEN-COV Fact Sheet:https://www.fda.gov/media/145611/download
Elizabeth W. Borella
23:11
Bam Fact Sheet:https://www.fda.gov/media/145802/download
Elizabeth W. Borella
23:54
As of July 30, 2021, FDA has authorized post exposureprophylaxis use of the COVID 19 monoclonal antibodytherapeutic REGEN COV (casirivimab and imdevimab)
Elizabeth W. Borella
24:14
Sub Q Info Sheet:https://www.phe.gov/emergency/events/COVID19/therapeutics/Documents/REGEN-COV-SubQ-FactSheet-July2021-508.pdf
Elizabeth W. Borella
33:32
Elizabeth Borella: Elizabeth.Woodland@Arkansas.gov
Sara Jones
43:08
Is there is a resource available providing a list of locations for patients or providers that may be seeking this treatment and ask?
John Vinson
44:28
https://www.healthy.arkansas.gov/programs-services/topics/covid-19-guidance-about-monoclonal-antibodies
John Vinson
44:59
scroll to the bottom of the ADH MAB website to see a map of locations and a search bar to find facilties offering MAB therapy
Elizabeth W. Borella
45:32
I'd like to add, if you don't see your facility listed please email me so I can add you. The following information is needed:
Elizabeth W. Borella
45:57
1. Facility name and address2. Hours of operation for infusion/SubQ3. How many patients your facility can treat per day4. Phone number patients can call if they are interested in monoclonal antibody therapy (will be added to our website)
Jenny Minchow
59:32
How is the reimbursement going?
Elizabeth W. Borella
01:09:01
To learn about coverage and reimbursement under Medicare, Medicaid, and Children’s Health Insurance Program (CHIP), see Coverage of Monoclonal Antibody Products to Treat COVID-19: https://www.cms.gov/files/document/covid-infographic-coverage-monoclonal-antibody-products-treat-covid-19.pdf increased CMS reimbursement rates for mAb administration: https://www.hrsa.gov/coviduninsuredclaim/frequently-asked-questions
Elizabeth W. Borella
01:10:29
For specific instructions on Medicare payments and billing, see Medicare Monoclonal Antibody COVID-19 Infusion Program Instruction: https://www.cms.gov/files/document/covid-medicare-monoclonal-antibody-infusion-program-instruction.pdf- To learn more about claims reimbursement for healthcare providers, see https://www.hrsa.gov/coviduninsuredclaim/frequently-asked-questions
Nicki Hilliard
01:16:49
Even if you can’t provide this service, please educate and refer patients for MAB therapy.
Kyle Hively, PharmD
01:19:07
Thank you all!